Announcements Trials
Browse Landscape

Phase

Phase 1 3Phase NA 2Phase 2 1Phase 1/2 1

Status

Completed 3Terminated 2

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Sarcoma 2CNS 2Lymphoid 1

Conditions

Glioblastoma 2Sarcoma 1Recurrence 1Medulloblastoma 1Lymphoma 1Gliosarcoma 1Glioma 1Carcinoma 1Astrocytoma 1

Interventions

Paclitaxel 292Gemcitabine 254Carboplatin 254Cisplatin 251Radiotherapy 219Cyclophosphamide 218Irinotecan 184pembrolizumab 181Docetaxel 174Bevacizumab 166Capecitabine 148Nivolumab 141Fluorouracil 132Dexamethasone 125Bortezomib 123Oxaliplatin 115Cytarabine 113Erlotinib Hydrochloride 112Temozolomide 110Sorafenib 110Doxorubicin 106Rituximab 105Leucovorin 105Etoposide 105Filgrastim 99Everolimus 97Lenalidomide 95Pemetrexed 90Ipilimumab 90fludarabine phosphate 84

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1 × Completed × Tetanus Toxoid × Clear all
NCT00639639 2023-03-13

ATTAC

Duke University

Phase 1 Completed
42 enrolled
CNSSarcoma

Glioblastoma, Gliosarcoma

NCT01644968 2022-05-17

Phase 1 Study of Anti-OX40 in Patients With Advanced Cancer

Providence Health & Services

Phase 1 Completed
30 enrolled
LymphoidSarcoma

Carcinoma, Lymphoma, Sarcoma

NCT03615404 2021-01-28

ATTAC-P

Duke University

Phase 1 Completed
11 enrolled 7 charts
CNS

Astrocytoma, Glioblastoma, Glioma, Medulloblastoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡